semaglutide shortage 2025 fda status january Federal judge upholds FDA's removal of Ozempic, Wegovy from drug list GLP-1 No Longer on FDA's – 🚨 FDA Ends Semaglutide Shortage

This is the core tension in the report: demand is excellent, but pricing pressure remains a visible headwind, especially for Mounjaro and Zepbound

For comparisons with next-generation triple agonists, see our retatrutide vs semaglutide analysis

Compound Semaglutide Injection $149 Compound Tirzepatide Injection $329 Is everything included in the price

When gastric emptying is delayed, carbonated beverages can increase gastric distension, bloating, and discomfort

M.et al (1992)

To mitigate potential discrepancies in baseline characteristics between the two study groups, we comprehensively integrated and algorithmically selected high-dimensional covariates assessed within 1 year before the index time